Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma

The genetics of renal cancer is dominated by inactivation of the VHL tumour suppressor gene in clear cell carcinoma (ccRCC), the commonest histological subtype. A recent large-scale screen of ∼3,500 genes by PCR-based exon re-sequencing identified several new cancer genes in ccRCC including UTX (also known as KDM6A), JARID1C (also known as KDM5C) and SETD2 (ref. 2). These genes encode enzymes that demethylate (UTX, JARID1C) or methylate (SETD2) key lysine residues of histone H3. Modification of the methylation state of these lysine residues of histone H3 regulates chromatin structure and is implicated in transcriptional control. However, together these mutations are present in fewer than 15% of ccRCC, suggesting the existence of additional, currently unidentified cancer genes. Here, we have sequenced the protein coding exome in a series of primary ccRCC and report the identification of the SWI/SNF chromatin remodelling complex gene PBRM1 (ref. 4) as a second major ccRCC cancer gene, with truncating mutations in 41% (92/227) of cases. These data further elucidate the somatic genetic architecture of ccRCC and emphasize the marked contribution of aberrant chromatin biology.

• Publication year

  2010

• Venue

  Nature

• Publication date

  2010-11-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nature09639PMID 21248752PMCID 3030920
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Polybromo-associated BRG1-associated factor components BRD7 and BAF180 are critical regulators of p53 required for induction of replicative senescence

  2010cited by this paper
• ARID1A mutations in endometriosis-associated ovarian carcinomas.

  2010cited by this paper
• Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome.

  2010cited by this paper
• Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma

  2010cited by this paper
• SWI/SNF Regulates the Cellular Response to Hypoxia*

  2009cited by this paper
• Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads

  2009cited by this paper
• A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma

  2009cited by this paper
• Polybromo-1: the chromatin targeting subunit of the PBAF complex.

  2009cited by this paper
• A Transposon-Based Genetic Screen in Mice Identifies Genes Altered in Colorectal Cancer

  2009cited by this paper
• Somatic mutations of the histone H3K27 demethylase, UTX, in human cancer

  2009cited by this paper
• Solution Hybrid Selection with Ultra-long Oligonucleotides for Massively Parallel Targeted Sequencing

  2009cited by this paper
• Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia

  2009cited by this paper
• The SWI/SNF complex and cancer

  2009cited by this paper
• Faculty Opinions recommendation of Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer.

  2009cited by this paper
• Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes

  2009cited by this paper
• BAF180 is a critical regulator of p21 induction and a tumor suppressor mutated in breast cancer.

  2008cited by this paper
• Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses

  2008cited by this paper
• Large-Scale Mutagenesis in p19ARF- and p53-Deficient Mice Identifies Cancer Genes and Their Collaborative Networks

  2008cited by this paper
• VHL loss actuates a HIF-independent senescence programme mediated by Rb and p400

  2008cited by this paper
• Polybromo-1-bromodomains bind histone H3 at specific acetyl-lysine positions.

  2007cited by this paper
• Chromatin modifications and their function.

  2007cited by this paper
• The 3p21 candidate tumor suppressor gene BAF180 is normally expressed in human lung cancer

  2005cited by this paper
• Cancer-associated mutations in chromatin remodeler hSNF5 promote chromosomal instability by compromising the mitotic checkpoint.

  2005cited by this paper
• Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse

  2005cited by this paper
• Expression of p270 (ARID1A), a component of human SWI/SNF complexes, in human tumors

  2004cited by this paper
• Genes, Chromosomes and Cancer

  2004cited by this paper
• Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse.

  2003cited by this paper
• HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron.

  2002cited by this paper
• BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines.

  2000cited by this paper
• The human SWI/SNF-B chromatin-remodeling complex is related to yeast rsc and localizes at kinetochores of mitotic chromosomes.

  2000cited by this paper
• Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.

  1998cited by this paper
• Inactivation of the von Hippel–Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: Evidence for a VHL‐independent pathway in clear cell renal tumourigenesis

  1998cited by this paper
• Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer

  1998cited by this paper
• Chromatin Modifications and Their Function

  year unknowncited by this paper

• Clinical, Pathologic, and Molecular Profiles of Sarcomatoid and Rhabdoid Differentiated Clear Cell Renal Cell Carcinoma: A Series of 21 Tumors.

  2026cites this paper
• Targeting HIF‐2α in renal cell carcinoma: Expanding upon belzutifan

  2026cites this paper
• PBRM1 Deficiency Reshapes an Immune Suppressive Microenvironment Through Epigenetic Tuning of PBRM1-KDM5C-IL6 Axis in ccRCC.

  2026cites this paper
• The SWI/SNF Complex in Tumor Metabolism: Mechanisms and Therapeutic Implications.

  2026cites this paper
• The fall of the genome protectors triad: PBRM1, SETD2, and BAP1’s impact on metabolism and immunity in clear cell renal cell carcinoma

  2026cites this paper
• Elucidating the Role of PBRM1 in NPC via RNA-seq Transcriptomic Sequencing.

  2025cites this paper
• Nanosize Non‐Viral Gene Therapy Reverses Senescence Reprograming Driven by PBRM1 Deficiency to Suppress iCCA Progression

  2025cites this paper
• The Role of Homologous Recombination Deficiency (HRD) in Renal Cell Carcinoma (RCC): Biology, Biomarkers, and Therapeutic Opportunities

  2025cites this paper
• Discovery of Novel, Potent, and Orally Bioavailable SMARCA2 Proteolysis-Targeting Chimeras with Synergistic Antitumor Activity in Combination with Kirsten Rat Sarcoma Viral Oncogene Homologue G12C Inhibitors

  2025cites this paper
• Prevailing challenges in personalized treatment for metastatic renal cell carcinoma: a narrative review

  2025cites this paper
• Nucleosome context regulates chromatin reader preference

  2025cites this paper
• The SLC1A1/EAAT3 dicarboxylic amino acid transporter is an epigenetically dysregulated nutrient carrier that sustains oncogenic metabolic programs

  2025cites this paper
• Single-cell Pharmacogenomic Landscapes of Epigenetic Drug Resistance Revealed by Gastric Cancer Perturb-seq

  2025cites this paper
• Oncolytic adenoviruses in bladder and kidney cancers: emerging strategies and next frontiers

  2025cites this paper
• French recommendations on multi-gene panel testing in renal cell carcinoma.

  2025cites this paper
• AI-driven multimodal algorithm predicts immunotherapy and targeted therapy outcomes in clear cell renal cell carcinoma

  2025cites this paper
• Molecular landscape of clear cell renal cell carcinoma: targeting the Wnt/β-catenin signaling pathway

  2025cites this paper
• Application of Proteomic and Metabolomic Technologies in Renal Cell Carcinoma and Research Progress of Related Biomarkers

  2025influential citation
• Translational Research Bridging Basic and Clinical Insights in Renal Cell Carcinoma: A Collaborative Review and Future Directions

  2025cites this paper
• Prognostic impact and landscape of cellular CXCR5 chemokine receptor expression in clear-cell renal cell carcinoma

  2025cites this paper
• Clear cell renal carcinoma essentially requires CDKL3 for oncogenesis

  2025cites this paper
• Liquid Biopsy as a New Tool for Diagnosis and Monitoring in Renal Cell Carcinoma

  2025cites this paper
• Integrating whole-exome sequencing and scRNA-seq reveal the characteristic in one clear cell renal cell carcinoma sample arising in the setting of VHL disease

  2025cites this paper
• Prognostic Implications of SMARCA4 , ARID1A , and Other BAF Mutations in Non‐Small Cell Lung Cancer

  2025cites this paper
• Prediction tools for assessing functional impacts of gene mutations in Clear Cell Renal Cell Carcinoma: A comparative study

  2025cites this paper
• Genomic profiling of urological malignancies using tissue-based next generation sequencing.

  2025cites this paper
• Disclosing the development and focus of sequencing and omics studies in kidney neoplasm research

  2025cites this paper
• Determinants of late metastases in renal cell carcinoma.

  2025cites this paper
• Chromatin remodeling complexes: architects influencing breast cancer progression

  2025cites this paper
• A SWI/SNF complex-related genes signature predicts prognosis and immune infiltration in ccRCC with KCNK5 as a novel biomarker

  2025cites this paper
• Multiomics in Renal Cell Carcinoma: Current Landscape and Future Directions for Precision Medicine

  2025cites this paper
• Deciphering the interplay between SETD2 mediated H3K36me3 and RNA N6-methyladenosine in clear cell renal cell carcinoma (ccRCC)

  2025cites this paper
• USP7 facilitates deubiquitination of LRRC42 in colorectal cancer to accelerate tumorigenesis and augment Wnt/β-catenin signaling.

  2024cites this paper
• Understanding Factors that Influence Prognosis and Response to Therapy in Clear Cell Renal Cell Carcinoma.

  2024cites this paper
• An incidental finding of a high-grade glioma with pleomorphic and pseudopapillary features (HPAP) with PBRM1 mutation.

  2024cites this paper
• Established and emerging biomarkers of immunotherapy in renal cell carcinoma.

  2024cites this paper
• Enhancer reprogramming underlies therapeutic utility of a SMARCA2 degrader in SMARCA4 mutant cancer.

  2024cites this paper
• ARID2 Deficiency Enhances Tumor Progression via ERBB3 Signaling in TFE3-Rearranged Renal Cell Carcinoma

  2024cites this paper
• Dual-loss of PBRM1 and RAD51 identifies hyper-sensitive subset patients to immunotherapy in clear cell renal cell carcinoma

  2024cites this paper
• Evaluation of PD-L1 expression in PBRM1-altered clear cell renal cell carcinoma.

  2024cites this paper
• ATF4/NUPR1 axis promotes cancer cell survival and mediates immunosuppression in clear cell renal cell carcinoma

  2024cites this paper
• Development of prognostic signatures and risk index related to lipid metabolism in ccRCC

  2024cites this paper
• Prognostic impact and genomic backgrounds of renal parenchymal infiltration or micronodular spread in non-metastatic clear cell renal cell carcinoma.

  2024cites this paper
• Opening and changing: mammalian SWI/SNF complexes in organ development and carcinogenesis

  2024cites this paper
• CDC20‐Mediated Selective Autophagy Degradation of PBRM1 Affects Immunotherapy for Renal Cell Carcinoma

  2024cites this paper
• Fast and accurate variant identification tool for sequencing-based studies

  2024cites this paper
• Chromatin remodellers as therapeutic targets

  2024cites this paper
• Chromatin Remodelers Are Regulators of the Tumor Immune Microenvironment.

  2024cites this paper
• The influence of sex hormones on renal cell carcinoma

  2024cites this paper
• A latent variable model for evaluating mutual exclusivity and co-occurrence between driver mutations in cancer

  2024cites this paper
• Radiogenomic analysis based on lipid metabolism-related subset for non-invasive prediction for prognosis of renal clear cell carcinoma.

  2024cites this paper
• ARID1A-BAF coordinates ZIC2 genomic occupancy for epithelial-to-mesenchymal transition in cranial neural crest specification

  2024cites this paper
• Preclinical Evidence in the Assembly of Mammalian SWI/SNF Complexes: Epigenetic Insights and Clinical Perspectives in Human Lung Diseases Therapy.

  2024cites this paper
• ARID1A loss is associated with increased NRF2 signaling in human head and neck squamous cell carcinomas

  2024cites this paper
• Research progress of SWI/SNF complex in breast cancer

  2024cites this paper
• Clinical protocol phase II study of tumor infiltrating lymphocytes in advanced tumors with alterations in the SWI/SNF complex: the TILTS study.

  2024cites this paper
• Therapeutic modulation of ROCK overcomes metabolic adaptation of cancer cells to OXPHOS inhibition and drives synergistic anti-tumor activity

  2024cites this paper
• The Killer’s Web: Interconnection between Inflammation, Epigenetics and Nutrition in Cancer

  2024cites this paper
• Development and characterisation of a large animal transgenic tumor model for sarcomatoid renal cell carcinoma

  2024cites this paper
• Association of circulating tumor DNA with patient prognosis in surgically resected renal cell carcinoma

  2024cites this paper
• Cancer-associated polybromo-1 bromodomain 4 missense variants variably impact bromodomain ligand binding and cell growth suppression

  2024cites this paper
• TNFSF9 Is Associated with Favorable Tumor Immune Microenvironment in Patients with Renal Cell Carcinoma Who Are Treated with the Combination Therapy of Nivolumab and Ipilimumab

  2024cites this paper
• PBRM1 loss is associated with increased sensitivity to MCL1 and CDK9 inhibition in clear cell renal cancer

  2024cites this paper
• Context-specific functions of chromatin remodellers in development and disease

  2023cites this paper
• The utilization of single-cell sequencing technology in investigating the immune microenvironment of ccRCC

  2023cites this paper
• An Overview of Renal Cell Carcinoma Hallmarks, Drug Resistance, and Adjuvant Therapies.

  2023cites this paper
• Detection Rate and Spectrum of Pathogenic Variations in a Cohort of 83 Patients with Suspected Hereditary Risk of Kidney Cancer

  2023cites this paper
• Dedifferentiated Endometrial Carcinoma: A Rare Aggressive Neoplasm-Clinical, Morphological and Immunohistochemical Features

  2023cites this paper
• The SWI/SNF Complex: A Frequently Mutated Chromatin Remodeling Complex in Cancer.

  2023cites this paper
• Translational Aspects of Epithelioid Sarcoma - Current Consensus.

  2023cites this paper
• A Rare Case of Synchronous Fumarate Hydratase-Deficient Renal Cell Carcinoma and Clear Cell Renal Cell Carcinoma With Fumarate Hydratase and von Hippel-Lindau Gene Mutations: A Clinicopathologic and Molecular Study

  2023cites this paper
• The SLC1A1/EAAT3 Dicarboxylic Amino Acid Transporter is an Epigenetically Dysregulated Nutrient Carrier that Sustains Oncogenic Metabolic Programs

  2023cites this paper
• Integrative Single-Cell Analysis Reveals Transcriptional and Epigenetic Regulatory Features of Clear Cell Renal Cell Carcinoma

  2023cites this paper
• The bromo-adjacent homology domains of PBRM1 associate with histone tails and contribute to PBAF-mediated gene regulation

  2023cites this paper
• GNE-235: A Lead Compound Selective for the Second Bromodomain of PBRM1.

  2023cites this paper
• Systematic analysis of RNASET2 gene as a potential prognostic and immunological biomarker in clear cell renal cell carcinoma

  2023cites this paper
• Current perspective on the impact of endogenous retroviruses in clear cell renal cell carcinoma.

  2023cites this paper
• Expression of targets of the RNA-binding protein AUF-1 in human airway epithelium indicates its role in cellular senescence and inflammation

  2023cites this paper
• SWI/SNF Complex Alterations in Tumors with Rhabdoid Features: Novel Therapeutic Approaches and Opportunities for Adoptive Cell Therapy

  2023cites this paper
• In vivo CRISPR/Cas9 screening identifies Pbrm1 as a regulator of myeloid leukemia development in mice

  2023cites this paper
• Hemangioblastomas and Other Vascular Origating Tumors of Brain or Spinal Cord.

  2023cites this paper
• SETD2-H3K36ME3: an important bridge between the environment and tumors

  2023cites this paper
• Multi-omics integration identifies cell-state-specific repression by PBRM1-PIAS1 cooperation

  2023cites this paper
• Relationship between body composition and PBRM1 mutations in clear cell renal cell carcinoma: a propensity score matching analysis

  2023cites this paper
• New molecular targets in Hodgkin and Reed-Sternberg cells

  2023cites this paper
• Predictive genomic biomarkers of therapeutic effects in renal cell carcinoma

  2023cites this paper
• Bile duct adenoma and small‐sized small duct type intrahepatic cholangiocarcinoma show distinct differences in genetic alterations, expression of IMP3 and EZH2 and stromal and inflammatory components

  2023cites this paper
• PBRM1 loss redirects chromatin remodelling complex to recruit oncogenic factors

  2023cites this paper
• Epigenetics in cancer development, diagnosis and therapy.

  2023cites this paper
• Immunobiology and Metabolic Pathways of Renal Cell Carcinoma.

  2023cites this paper
• PBRM1-deficient PBAF complexes target aberrant genomic loci to activate the NF-κB pathway in clear cell renal cell carcinoma

  2023cites this paper
• Current Landscape of Genomic Biomarkers in Clear Cell Renal Cell Carcinoma.

  2023cites this paper
• Recent insights into the SWI/SNF complex and the molecular mechanism of hSNF5 deficiency in rhabdoid tumors

  2023cites this paper
• Genomic profiles of renal cell carcinoma in a small Chinese cohort

  2023cites this paper
• Construction and validation of a prognostic model for predicting clear cell renal cell carcinoma based on complement-related genes

  2023cites this paper
• Treatment strategies for clear cell renal cell carcinoma: Past, present and future

  2023cites this paper
• Coordinated alternation of DNA methylation and alternative splicing of PBRM1 affect bovine sperm structure and motility

  2023cites this paper
• Tumor microenvironment-based signatures distinguish intratumoral heterogeneity, prognosis, and immunogenomic features of clear cell renal cell carcinoma

  2023cites this paper
• Inflammatory Networks in Renal Cell Carcinoma

  2023cites this paper
• Epigenetic Regulation in Primary CNS Tumors: An Opportunity to Bridge Old and New WHO Classifications

  2023cites this paper